A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression

被引：1
|
作者：
Can, Adem T. T. [1 ]
Hermens, Daniel F. F. [1 ]
Lagopoulos, Jim [1 ]
机构：
[1] Univ Sunshine Coast, Thompson Inst, Birtinya, QLD, Australia
来源：
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词：
depression; ketamine; MADRS; NMDA; suicidality; treatment-resistant; TRIAL; DISORDER; STRESS;
D O I：
10.1002/ccr3.6675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series
    Tham, Joseph C. W.
    Do, Andre
    Fridfinnson, Jason
    Rafizadeh, Reza
    Siu, Jacky T. P.
    Budd, George P.
    Lam, Raymond W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (05) : 206 - 214
  • [2] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Ribeiro, Carolina Medeiros da Frota
    Riva-Posse, Patricio
    CURRENT PSYCHIATRY REPORTS, 2017, 19 (12)
  • [3] Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression
    Chen, Mu-Hong
    Wu, Hui-Ju
    Li, Cheng-Ta
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Mao, Wei-Chung
    Su, Tung-Ping
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (02)
  • [4] Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
    Feifel, David
    Malcolm, Benjamin
    Boggie, Danielle
    Lee, Kelly
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 221 : 283 - 288
  • [5] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [6] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [7] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [8] Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Bai, Ya-Mei
    Li, Cheng-Ta
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Cheng, Chih-Ming
    Su, Tung-Ping
    CNS SPECTRUMS, 2021, 26 (04) : 362 - 367
  • [9] Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series
    Al Shirawi, Maryam I.
    Kennedy, Sidney H.
    Ho, Keith T.
    Byrne, Roisin
    Downar, Jonathan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 464 - 467
  • [10] Acute and Maintenance Response of Serial Low-Dose Ketamine Infusion for Treatment Resistant Major Depression
    Lineberry, Timothy
    Rasmussen, Keith
    Kung, Simon
    Sola, Christopher
    Palmer, Brian
    Hanson, Allison
    Ritter, Matthew
    Lapid, Maria
    Galardy, Christine
    Schak, Kathryn
    Frye, Mark A.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 101S - 101S
12345